Published in Lancet Oncol on September 01, 2003
Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol (2010) 2.48
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res (2009) 1.93
Positive affect and inflammation during radiation treatment for breast and prostate cancer. Brain Behav Immun (2009) 1.54
Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys (2007) 1.49
Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med (2009) 1.47
Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36
Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology (2013) 1.31
Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res (2008) 1.30
Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29
Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer (2005) 1.23
Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist (2010) 1.23
Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat Res (2010) 1.17
Perineal wound complications after abdominoperineal resection. Clin Colon Rectal Surg (2008) 1.08
Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol (2013) 1.06
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol (2006) 1.05
Immunogenic cell death in radiation therapy. Oncoimmunology (2013) 1.04
Normal tissue protection for improving radiotherapy: Where are the Gaps? Transl Cancer Res (2012) 1.03
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov (2014) 1.03
Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization. ACS Nano (2014) 1.01
Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring. PLoS One (2011) 1.00
PAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injury. PLoS One (2012) 0.98
Adipose tissue sensitivity to radiation exposure. Am J Pathol (2008) 0.97
Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology (2012) 0.97
Rapid loss of bone mass and strength in mice after abdominal irradiation. Radiat Res (2011) 0.96
The histopathologic evaluation of soft tissue changes in rabbit extremity after different dose-fractionation schemes of interstitial high dose rate (HDR) brachytherapy. Rep Pract Oncol Radiother (2010) 0.95
Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity. Int J Mol Sci (2013) 0.93
Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer. Support Care Cancer (2012) 0.92
Antioxidants reduce consequences of radiation exposure. Adv Exp Med Biol (2008) 0.91
Acute and persisting Th2-like immune response after fractionated colorectal gamma-irradiation. World J Gastroenterol (2008) 0.91
Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev (2008) 0.91
Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study. BMC Cancer (2013) 0.91
Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology (2014) 0.91
Antioxidant properties of probiotics and their protective effects in the pathogenesis of radiation-induced enteritis and colitis. Dig Dis Sci (2010) 0.91
Cancer as an emergent phenomenon in systems radiation biology. Radiat Environ Biophys (2007) 0.91
Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations. Br J Cancer (2007) 0.90
Old but new methods in radiation oncology: hyperbaric oxygen therapy. Int J Clin Oncol (2013) 0.90
Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med (2006) 0.89
Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Community Oncol (2010) 0.89
Post-radiation changes in oral tissues - An analysis of cancer irradiation cases. South Asian J Cancer (2014) 0.89
Opportunities for rehabilitation of patients with radiation fibrosis syndrome. Rep Pract Oncol Radiother (2013) 0.88
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. Surg Endosc (2013) 0.88
Stem cell therapy remediates reconstruction of the craniofacial skeleton after radiation therapy. Stem Cells Dev (2013) 0.87
Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc (2009) 0.87
Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals. Mol Biol Cell (2012) 0.86
Comprehensive assessment of host responses to ionizing radiation by nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis. PLoS One (2011) 0.86
Effects of low dose X-ray irradiation on porcine articular cartilage explants. J Orthop Res (2013) 0.85
Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol (2011) 0.85
The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy. PLoS One (2013) 0.85
The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res (2012) 0.85
Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage. Cell J (2013) 0.85
Photoacoustic monitoring of tumor and normal tissue response to radiation. Sci Rep (2016) 0.84
Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets. Biomol Ther (Seoul) (2012) 0.84
Aging attenuates radiation-induced expression of pro-inflammatory mediators in rat brain. Neurosci Lett (2010) 0.84
Nrf2 promotes survival following exposure to ionizing radiation. Free Radic Biol Med (2015) 0.84
Enhanced survival from radiation pneumonitis by combined irradiation to the skin. Int J Radiat Biol (2014) 0.84
Inflammatory biomarkers and emotional approach coping in men with prostate cancer. Brain Behav Immun (2013) 0.83
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83
Selenoprotein P inhibits radiation-induced late reactive oxygen species accumulation and normal cell injury. Int J Radiat Oncol Biol Phys (2013) 0.83
The diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance. Am J Cancer Res (2012) 0.83
Evaluating Radioprotective Effect of Hesperidin on Acute Radiation Damage in the Lung Tissue of Rats. J Biomed Phys Eng (2016) 0.82
Re-operative thyroid surgery: a 20-year prospective cohort study at a tertiary referral centre. Eur Arch Otorhinolaryngol (2014) 0.82
Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors. Nucl Med Biol (2013) 0.82
The prospective role of plant products in radiotherapy of cancer: a current overview. Front Pharmacol (2012) 0.82
Re-assessment of chronic radio-induced tissue damage in a rat hindlimb model. Exp Ther Med (2010) 0.82
Antioxidative and radioprotective potential of rutin and quercetin in Swiss albino mice exposed to gamma radiation. J Med Phys (2013) 0.82
The effect of Amifostine prophylaxis on bone densitometry, biomechanical strength and union in mandibular pathologic fracture repair. Bone (2013) 0.82
Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs. Radiat Res (2014) 0.81
SKI2162, an inhibitor of the TGF-β type I receptor (ALK5), inhibits radiation-induced fibrosis in mice. Oncotarget (2015) 0.81
Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits. Clin Oncol (R Coll Radiol) (2015) 0.81
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology (2016) 0.81
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. Int J Cancer (2014) 0.81
Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis. PLoS One (2015) 0.80
Effects of carbon ion beam irradiation on lung injury and pulmonary fibrosis in mice. Exp Ther Med (2013) 0.80
Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort. Cancer (2015) 0.80
The management of perineal wounds. Indian J Plast Surg (2012) 0.80
Basic Fibroblast Growth Factor Ameliorates Endothelial Dysfunction in Radiation-Induced Bladder Injury. Biomed Res Int (2015) 0.80
Effects of age and radiation treatment on function of extrinsic tongue muscles. Radiat Oncol (2014) 0.80
TGF-β1 rs1982073 polymorphism contributes to radiation pneumonitis in lung cancer patients: a meta-analysis. J Cell Mol Med (2016) 0.80
Quantitative Evaluation of Rabbit Brain Injury after Cerebral Hemisphere Radiation Exposure Using Generalized q-Sampling Imaging. PLoS One (2015) 0.79
Intestinal microbiota-derived metabolomic blood plasma markers for prior radiation injury. Int J Radiat Oncol Biol Phys (2015) 0.79
Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non-prostate malignancies. BJU Int (2009) 0.79
The effects of high dose and highly fractionated radiation on distraction osteogenesis in the murine mandible. Radiat Oncol (2012) 0.79
Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model. Oncol Lett (2013) 0.79
Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation. Radiat Res (2015) 0.79
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. J Neurooncol (2015) 0.79
Effects of Radiation on Spinal Dura Mater and Surrounding Tissue in Mice. PLoS One (2015) 0.78
Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol (2014) 0.78
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy. Int J Colorectal Dis (2014) 0.78
Urethral strictures after radiation therapy for prostate cancer. Investig Clin Urol (2016) 0.78
MRI findings of radiation-induced changes of masticatory muscles: a systematic review. J Otolaryngol Head Neck Surg (2013) 0.78
Adipose-derived stem cells in radiotherapy injury: a new frontier. Front Surg (2015) 0.78
Cancer cell motility: optimizing spatial search strategies. Biosystems (2008) 0.78
Promotion of cAMP responsive element-binding protein activity ameliorates radiation-induced suppression of hippocampal neurogenesis in adult mice. Toxicol Res (2010) 0.78
Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study. Radiat Res (2015) 0.78
Zebrafish as a model system to screen radiation modifiers. Curr Genomics (2007) 0.78
Acute effects of radiation treatment: skin reactions. Can Vet J (2006) 0.77
Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. Future Neurol (2012) 0.77
Modulation expression of tumor necrosis factor α in the radiation-induced lung injury by glycyrrhizic acid. J Med Phys (2015) 0.77
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol (2003) 11.94
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 10.06
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med (2004) 5.63
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol (2007) 5.23
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res (2005) 3.57
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res (2004) 2.91
Animal models for medical countermeasures to radiation exposure. Radiat Res (2010) 2.83
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. Int J Radiat Oncol Biol Phys (2012) 2.55
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol (2003) 2.51
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 2.42
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res (2004) 2.33
Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys (2005) 2.29
Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site. Oncology (Williston Park) (2009) 2.08
Radiologic and nuclear events: contingency planning for hematologists/oncologists. Blood (2008) 1.96
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol (2006) 1.96
Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep (2011) 1.93
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res (2007) 1.91
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin Cancer Res (2003) 1.83
Radiation-induced lung injury. Semin Radiat Oncol (2003) 1.82
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. J Clin Oncol (2009) 1.82
Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells (2010) 1.78
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med (2004) 1.71
The biological effectiveness of antiproton irradiation. Radiother Oncol (2006) 1.66
Rapid radiation dose assessment for radiological public health emergencies: roles of NIAID and BARDA. Health Phys (2010) 1.65
A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med (2002) 1.65
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys (2005) 1.64
T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res (2008) 1.61
Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep (2011) 1.60
Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys (2011) 1.60
The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int J Radiat Oncol Biol Phys (2004) 1.59
The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res (2006) 1.51
A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys (2005) 1.48
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Clin Cancer Res (2006) 1.48
Comparing radical prostatectomy and brachytherapy for localized prostate cancer. Oncology (Williston Park) (2004) 1.46
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys (2007) 1.46
Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res (2006) 1.45
Normal tissue effects: reporting and analysis. Semin Radiat Oncol (2003) 1.44
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys (2004) 1.44
In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (INT J RADIAT ONCOL BIOL PHYS 2004;58:1378-1387). Int J Radiat Oncol Biol Phys (2005) 1.44
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. J Immunol (2004) 1.44
Walking forward: the South Dakota Native American project. J Cancer Educ (2005) 1.44
Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol (2010) 1.43
National Institutes of Health funding in radiation oncology: a snapshot. Int J Radiat Oncol Biol Phys (2013) 1.42
Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2003) 1.42
Accelerated partial-breast irradiation: trial by media or by science? Int J Radiat Oncol Biol Phys (2012) 1.41
Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations. Oncology (Williston Park) (2016) 1.40
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy. J Immunother (2004) 1.40
Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol (2007) 1.40
Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys (2010) 1.39
Are radiation oncologists serious about systemic radiation therapy and if not, should we be? Int J Radiat Oncol Biol Phys (2004) 1.39
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology (2008) 1.32
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res (2002) 1.31
Disaster preparation: lessons from Japan. Science (2011) 1.30
Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (2007) 1.29
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int J Radiat Oncol Biol Phys (2007) 1.28
Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation. Free Radic Res (2007) 1.25
After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS). Int J Radiat Biol (2011) 1.24
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Clin Cancer Res (2003) 1.24
Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer (2005) 1.23
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Clin Cancer Res (2010) 1.22
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol (2004) 1.21
The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin Cancer Res (2005) 1.20
Links between innate immunity and normal tissue radiobiology. Radiat Res (2010) 1.19
Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res (2009) 1.19
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res (2006) 1.18
Salvage radiotherapy for recurrent prostate cancer: the earlier the better. JAMA (2004) 1.17
Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2005) 1.16
Biological dosimetry by the triage dicentric chromosome assay: potential implications for treatment of acute radiation syndrome in radiological mass casualties. Radiat Res (2011) 1.16
Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations. Health Phys (2013) 1.14
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys (2006) 1.12
PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer (2008) 1.12
Compartmental responses after thoracic irradiation of mice: strain differences. Int J Radiat Oncol Biol Phys (2005) 1.11
First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep (2011) 1.10
Radiation responses of cancer stem cells. J Cell Biochem (2009) 1.08
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys (2007) 1.08
Fractionated radiation therapy can induce a molecular profile for therapeutic targeting. Radiat Res (2010) 1.08
Anthracyclines, proteasome activity and multi-drug-resistance. BMC Cancer (2005) 1.08
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res (2012) 1.06
The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol (2011) 1.05
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells. Mol Cancer Ther (2009) 1.05
Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer? Cytokine (2006) 1.05
Physical activity and sedentary behavior of cancer survivors and non-cancer individuals: results from a national survey. PLoS One (2013) 1.05
Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function. Clin Cancer Res (2004) 1.05
Salvage radiation in men after prostate-specific antigen failure and the risk of death. Cancer (2011) 1.04
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells (2009) 1.03
Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J Immunother (2004) 1.03
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer (2007) 1.03
Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther (2005) 1.02
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res (2012) 1.02
High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res (2009) 1.02
Tumor hypoxia: chicken, egg, or a piece of the farm? J Clin Oncol (2002) 1.02
Evaluation of radiation-induced oral mucositis by optical coherence tomography. Clin Cancer Res (2005) 1.01
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. Free Radic Biol Med (2002) 1.01
Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin Cancer Res (2003) 1.00
Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury. Int J Radiat Biol (2003) 1.00